Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.29. At the end of 2024 the company had a P/S ratio of 1.14.